These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1906197)

  • 21. Inhibition of human leukocyte elastase by chemically and naturally oversulfated galactosaminoglycans.
    Bartolucci C; Cellai L; Iannelli MA; Lamba D; Liverani L; Mascellani G; Perola E
    Carbohydr Res; 1995 Oct; 276(2):401-8. PubMed ID: 8542607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of drugs used in the treatment of thrombotic and hemorrhagic conditions on the erythrocyte aggregation].
    Lakin KM; Ovnatanova MS
    Kardiologiia; 1977 May; 17(5):79-83. PubMed ID: 886757
    [No Abstract]   [Full Text] [Related]  

  • 23. Profibrinolytic and anticoagulant properties of the pentosan polysulphate derivative bego 0391.
    Klöcking HP; Hauptmann J; Richter M
    Pharmazie; 1991 Jul; 46(7):543-4. PubMed ID: 1723804
    [No Abstract]   [Full Text] [Related]  

  • 24. Antithrombotic activity of Desmin 370. Comparison with a high molecular weight dermatan sulfate.
    Barbanti M; Calanni F; Babbini M; Bergonzini G; Parma B; Marchi E; Wassermann A
    Thromb Res; 1993 Sep; 71(5):417-22. PubMed ID: 8236168
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombotic activity of the superoxide dismutase-chondroitin sulfate complexes in a rat model of arterial injury.
    Maksimenko AV; Tischenko EG; Golubykh VL
    Cardiovasc Drugs Ther; 1999 Nov; 13(6):479-84. PubMed ID: 10686656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of molecular weight upon the anticoagulant and pharmacokinetic properties of dermatan sulfate in the rabbit.
    Saivin S; Dol F; Caranobe C; Petitou M; Lormeau JC; Sie P; Houin G; Boneu B
    Thromb Res; 1992 Jun; 66(5):527-35. PubMed ID: 1523609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the antithrombogenic action of low molecular weight heparins and of chondroitins A, B and C.
    Copley AL; King RG; Chien S
    Biorheology; 1983; 20(5):697-704. PubMed ID: 6428487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic heparin analogue and prothrombin time.
    Kakkar VV; Djazaeri B; Scully M; Weerasinghe K
    Lancet; 1981 May; 1(8230):1167. PubMed ID: 6112524
    [No Abstract]   [Full Text] [Related]  

  • 29. Dermatan sulfate enhances the lysis of laser-induced thrombus in vivo.
    Krupinski K; Bielawiec M; Yoshida K; Kyogashima M; Takada Y; Takada A
    Thromb Res; 1998 Aug; 91(4):199-202. PubMed ID: 9736423
    [No Abstract]   [Full Text] [Related]  

  • 30. How drugs act-17. Drugs and the blood.
    Smith SE
    Nurs Times; 1975 Oct; 71(42):1665-6. PubMed ID: 1196926
    [No Abstract]   [Full Text] [Related]  

  • 31. International Conference on Thrombolysis. Paris, March 15, 1985.
    Haemostasis; 1986; 16 Suppl 3():1-152. PubMed ID: 3770535
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on heart. XXIV. Inhibitory effect of antiarrhythmic peptide (AAP) on experimental thromboses.
    Aonuma S; Kohama Y; Makino T; Hattori K; Kawahara Y
    Chem Pharm Bull (Tokyo); 1984 Jan; 32(1):219-27. PubMed ID: 6547078
    [No Abstract]   [Full Text] [Related]  

  • 33. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic profile of sulfamino-galactosaminoglycans.
    Pescador R; Porta R; Mantovani M; Prino G; Casu B; Naggi A; Torri G; Walenga JM; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():74-9. PubMed ID: 1906197
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ; Santos GR; Mourão PA
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and functional heterogeneity in dermatan sulfate preparations.
    Fareed J; Hoppensteadt D; Walenga JM; Ahsan A; Coyne E; Breddin HK
    Semin Thromb Hemost; 1991; 17 Suppl 2():174-80. PubMed ID: 1948088
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.